Immatics US launched to develop adoptive cellular therapies
26 August 2015 | By Victoria White
Immatics US is a new company aimed at becoming a global leader in adoptive cellular therapies (ACT) for the treatment of a range of tumour types...
List view / Grid view
News
Oncodrone to progress prostate cancer drug with €2.5m grant
25 August 2015 | By Victoria White
Oncodrone, the anti-cancer company based in Nijmegen, has been granted a € 2,5 million Eurostars grant for the development of its lead drug OCD155...
Major advance towards long-lasting universal influenza vaccine
25 August 2015 | By Victoria White
Scientists from The Scripps Research Institute (TSRI) and Janssen have found a way to induce antibodies to fight a wide range of influenza subtypes...
MorphoSys and Immatics enter immuno-oncology alliance
25 August 2015 | By Victoria White
MorphoSys and Immatics have formed an alliance to generate antibody-based therapeutics against multiple proprietary cancer antigens recognised by T cells...
Ocata receives SBIR grant to develop HMC therapy for lupus nephritis
24 August 2015 | By Victoria White
Ocata has been awarded a SBIR Phase 1 grant to fund further preclinical development of Ocata’s proprietary Hemangio-derived Mesenchymal Cell (HMC) product...
New drug protects against the effects of nuclear radiation
24 August 2015 | By Victoria White
A research team led by The University of Texas Medical Branch have reported a new breakthrough in countering the deadly effects of radiation exposure...
Efficacy of iclaprim confirmed in independent laboratory study
24 August 2015 | By Victoria White
Motif Bio has announced the topline results of an independent report that show iclaprim is effective in vitro against a range of Gram-positive bacteria...
Scientists replicate newt cell regeneration with human cells
21 August 2015 | By Victoria White
Scientists have adapted the astonishing capacity of newts to regenerate tissue to rejuvenate cells from older people with osteoarthritis...
Janus Biotherapeutics and Roche collaborate on autoimmune disease therapies
20 August 2015 | By Victoria White
Janus Biotherapeutics has entered into a collaboration with Roche for the development of a small molecule toll-like receptor (TLR) inhibitor...
Molecular feedback process may protect against Alzheimer’s
20 August 2015 | By Victoria White
Scientists have identified a series of naturally occurring molecular steps—known as a pathway—that can dampen the production of amyloid-β...
New insights into blocking asthma ‘pathways’
20 August 2015 | By Victoria White
Researchers have discovered new insights into how asthma may be caused, by identifying the activity of different genes in an individual's airways...
MERS-CoV vaccine successfully tested in monkeys and camels
20 August 2015 | By Victoria White
Scientists have reported that an experimental vaccine given six weeks before exposure to MERS-CoV fully protects rhesus macaques from disease...
New high-throughput screening method could speed drug discovery
19 August 2015 | By Victoria White
Scientists have developed a potentially better and more accurate high-throughput screening technique and have used it to identify 24 drug candidates...
Roche to acquire Kapa Biosystems
19 August 2015 | By Victoria White
Roche has signed a definitive agreement to acquire Kapa Biosystems, strengthening Roche's next-generation sequencing product offerings...
AmpliPhi Biosciences receives approval for listing on NYSE MKT
19 August 2015 | By Victoria White
AmpliPhi Biosciences Corporation has announced that its shares of common stock have been approved for listing on the NYSE MKT...